SHENYANG, China, Aug. 25 /Xinhua-PRNewswire-FirstCall/ -- 3SBio Inc. (NASDAQ:SSRX), a leading biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products primarily in China, announces that David Chen, Chief Operating Officer will present at the Morgan Stanley Global Healthcare Unplugged Conference in New York on Tuesday, September 9, 2008 at 8:35 AM.
A copy of the latest investor presentation will be available on the Investors page of the 3SBio website at: http://bbs.3sbio.com/en/News/ShowInfo_nnn6.aspx?ID=65 .
About 3SBio Inc.
3SBio Inc. is a leading, fully integrated biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, primarily in China.
For more information, please visit 3SBio on the web at: http://www.3sbio.com/
For more information, please contact:
Investor Contact:
David Chen, COO
3SBio Inc.
Tel: +86-24-2581-1820
Investor Relations (US):
Mahmoud Siddig
Taylor Rafferty
Tel: +1-212-889-4350
Investor Relations (HK):
Ruby Yim
Taylor Rafferty
Tel: +852-3196-3712
Media Contact:
Jason Marshall
Taylor Rafferty
Tel: +1-212-889-4350
DATASOURCE: 3SBio Inc.
CONTACT: David Chen, COO of 3SBio Inc. at +86-24-2581-1820; Investor
Relations (US): Mahmoud Siddig, Taylor Rafferty, at +1-212-889-4350; Investor
Relations (HK): Ruby Yim, Taylor Rafferty, at +852-3196-3712; or Media Contact:
Jason Marshall, Taylor Rafferty, at +1-212-889-4350 all for 3SBio Inc.
Web site: http://www.3sbio.com/